2026年4月30日 18:54 ET 发布 · 更新于 6 个月前 · 1 个来源
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
bloomberg
·
原始报道
INFERY
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public offering that priced at the top of a marketed range.
原文